| |
| |
|
| Insider
Information: |
Gryska David W |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
174,851 |
|
|
Indirect Shares
|
750 |
|
|
| Direct
Value |
$985,752 |
|
|
|
Indirect Value
|
$81,180 |
|
|
| Total
Shares |
175,601 |
|
|
| Total
Value |
$1,066,932 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
8
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 15.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2006-02-14 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
Chief Financial Officer |
2010-05-04 |
864 |
2010-05-04 |
750 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2020-12-30 |
1,387 |
2014-03-06 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Executive Vice Preside... |
2018-07-16 |
10,235 |
2015-01-08 |
0 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Director |
2022-11-21 |
0 |
2022-11-21 |
0 |
Premium* |
|
|
Mind Medicine |
MNMD |
Director |
2023-06-21 |
13,851 |
2023-06-21 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Director |
2023-07-31 |
148,514 |
2023-07-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
|
– • – |
2023-12-14 |
4 |
D |
$229.00 |
$11,221,687 |
D/D |
(49,003) |
0 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-04-10 |
4 |
AS |
$138.00 |
$5,730,864 |
D/D |
(41,528) |
19,015 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-04-10 |
4 |
OE |
$67.06 |
$2,784,868 |
D/D |
41,528 |
60,543 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-11-19 |
4 |
S |
$173.25 |
$2,605,523 |
D/D |
(15,000) |
44,848 |
0 |
% |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-03 |
4 |
S |
$61.63 |
$2,003,073 |
D/D |
(32,499) |
0 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-06-12 |
4 |
AS |
$116.60 |
$1,953,750 |
D/D |
(16,756) |
19,015 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2010-05-03 |
4 |
OE |
$49.61 |
$1,653,025 |
D/D |
32,499 |
7,499 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
S |
$64.50 |
$1,500,528 |
D/D |
(23,264) |
0 |
0 |
- |
|
| CELG |
Celgene Corp |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
OE |
$57.58 |
$1,339,541 |
D/D |
23,264 |
23,264 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-06-12 |
4 |
OE |
$73.21 |
$1,226,707 |
D/D |
16,756 |
35,771 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-11-11 |
4 |
S |
$129.10 |
$968,220 |
D/D |
(7,500) |
40,253 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-11-05 |
4 |
S |
$180.60 |
$812,699 |
D/D |
(4,500) |
44,848 |
0 |
% |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-01-05 |
4 |
AS |
$98.87 |
$668,361 |
D/D |
(6,760) |
13,992 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-02-07 |
4 |
AS |
$137.45 |
$624,441 |
D/D |
(4,500) |
46,250 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-01-14 |
4 |
AS |
$135.24 |
$608,581 |
D/D |
(4,500) |
46,250 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-04-19 |
4 |
AS |
$143.32 |
$575,783 |
D/D |
(4,000) |
46,250 |
0 |
% |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2018-01-05 |
4 |
OE |
$83.83 |
$566,691 |
D/D |
6,760 |
20,752 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-01-28 |
4 |
AS |
$121.69 |
$551,539 |
D/D |
(4,500) |
46,250 |
0 |
% |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-11-05 |
4 |
S |
$43.57 |
$435,737 |
D/D |
(10,000) |
23,950 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-10-01 |
4 |
AS |
$84.85 |
$425,450 |
D/D |
(5,000) |
48,013 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-09-03 |
4 |
S |
$42.48 |
$424,800 |
D/D |
(10,000) |
22,000 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-11-01 |
4 |
D |
$107.96 |
$422,447 |
D/D |
(3,913) |
17,907 |
0 |
- |
|
| INCY |
Incyte Corp |
Executive Vice President, CFO |
• – – |
2017-11-02 |
4 |
AS |
$105.63 |
$413,541 |
D/D |
(3,915) |
13,992 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-07-17 |
4 |
AS |
$75.00 |
$375,000 |
D/D |
(5,000) |
48,013 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-04-01 |
4 |
AS |
$73.38 |
$367,030 |
D/D |
(5,000) |
45,050 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
